Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers
- Li Xiao†1,
- Yun-Peng Liu†1,
- Chuan-Xing Xiao†1,
- Jian-Lin Ren1Email author and
- Bayasi Guleng1, 2Email author
© Xiao et al.; licensee BioMed Central Ltd. 2014
Received: 13 June 2013
Accepted: 10 June 2014
Published: 14 June 2014
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|13 Jun 2013||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|11 Oct 2013||Reviewed||Reviewer Report - Fekicity EB May|
|14 Oct 2013||Reviewed||Reviewer Report - Eliana Bignotti|
|11 Nov 2013||Author responded||Author comments - Bayasi Guleng|
|Resubmission - Version 4|
|11 Nov 2013||Submitted||Manuscript version 4|
|6 Jan 2014||Reviewed||Reviewer Report - Fekicity EB May|
|20 May 2014||Reviewed||Reviewer Report - Mohamed Shoukri|
|26 May 2014||Reviewed||Reviewer Report - John Hughes|
|10 Jun 2014||Author responded||Author comments - Bayasi Guleng|
|Resubmission - Version 5|
|10 Jun 2014||Submitted||Manuscript version 5|
|10 Jun 2014||Editorially accepted|
|14 Jun 2014||Article published||10.1186/1472-6890-14-26|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.